Post-earnings recap
Reported
Tue, Feb 27, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
63%
Dexcom's earnings report shows a significant miss on EPS, which contributed to a 2.19% decline in stock price. The lack of revenue data and guidance may raise concerns among investors about the company's short-term outlook. Management's defensive tone suggests they are aware of the challenges ahead but are committed to long-term growth.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.11 | N/A | -305.90% |
| Revenue | N/A | N/A | N/A |
Management expressed concerns about recent performance but remains focused on future opportunities. They did not provide specific guidance for upcoming quarters.
Management acknowledged the challenges faced during the quarter.
They emphasized a focus on long-term growth despite short-term setbacks.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—